Pentasa and hepatic function abnormal Patient Reports February 13, 2012

Pentasa Side Effects Report #5381288-X
Pentasa side effect was reported by a Consumer or non-health professional from DENMARK on June 07, 2006. Male patient, 75 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: hepatic function abnormal, pyrexia. Pentasa dosage: 750 MG, 3X/DAY:TID, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5381266-0
Pentasa side effect was reported by a Physician from DENMARK on Apr 13, 2007. Female patient, 34 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: aplastic anaemia, hepatic function abnormal, urticaria. Pentasa dosage: 750 MG 3X'S DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4930978-9
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Feb 13, 2006. Male patient, 33 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: colitis ulcerative, disease recurrence, hepatic function abnormal. Pentasa dosage: 500 MG, 3X/DAY:TID, ORAL. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4964968-7
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2006. Male patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: azoospermia, hepatic function abnormal. Pentasa dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.


Pentasa Side Effects Report #4842428-1
Pentasa side effect was reported by a Consumer or non-health professional from JAPAN on Nov 14, 2005. Male patient, 27 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hepatic steatosis. Pentasa dosage: 1500 MG DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5065246-0
Pentasa side effect was reported by a Consumer or non-health professional from DENMARK on May 08, 2006. Female patient, 19 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Pentasa dosage: 750 MG, 3X/DAY:TID, ORAL. During the same period patient was treated with FAMOTIDINE, PREDNISOLONE PHOSPHATE, FERROSFERRIC OXIDE. Patient recovered.

Pentasa Side Effects Report #5065438-0
Pentasa side effect was reported by a Consumer or non-health professional from DENMARK on Nov 25, 2005. Male patient, 15 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: hepatic function abnormal, nephritis interstitial, pancreatitis. Pentasa dosage: unknown. During the same period patient was treated with PREDNISOLONE PHOSPHATE, CEFTAZIDINE, FAMOTIDINE, TEPRENONE. Patient recovered.